Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$161.52+0.73 (+0.45%)
Close on Nov 2, 2026Market cap $308.20BP/E 22.6Yield –
Novartis Emerging Growth Markets: $13,977M in FY2025, up 8.0% from a year earlier.
Latest, FY2025
13,977
Period ended Dec 31, 2025
Change on a year earlier
+8.0%
12,946 in FY2024
History
5 years
Since FY2021
Sources
4
Documents cited below
Where the FY2025 figure comes from
“|| Of which in emerging growth markets | 13 977 | 12 946 | 8 | 10 | 26 | 26”
Source: Novartis Form 6-K (0001114448-26-000007) ↗
Reported in Form 6-K & Form 20-F.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Emerging Growth Markets ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 13,977 | +8.0% | Novartis Form 6-K (0001114448-26-000007) ↗ |
| FY2024 | Dec 31, 2024 | 12,946 | +10.5% | Novartis Form 6-K (0001114448-26-000007) ↗ |
| FY2023 | Dec 31, 2023 | 11,715 | +8.3% | Novartis Form 6-K (0001370368-25-000007) ↗ |
| FY2022 | Dec 31, 2022 | 10,820 | +2.1% | Novartis Form 6-K (0001370368-24-000007) ↗ |
| FY2021 | Dec 31, 2021 | 10,598 | – | Novartis Form 20-F (0001370368-24-000004) ↗ |
Breakdown
What makes up emerging Growth Markets
Cite this data
StockData. (2026). Novartis Emerging Growth Markets ($M), annual FY2021–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/geo-emerging-markets
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.